v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows From Operating Activities:    
Net income (loss) $ 89,945,000 $ (96,079,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Impairment loss   63,809,000
Depreciation and amortization 21,357,000 22,863,000
Amortization of debt discount 925,000 1,622,000
Non-cash operating lease expense 5,304,000 4,391,000
Unrealized gain on investments in equity securities (1,663,000) (1,445,000)
Realized loss on investments in equity securities   48,000
Realized loss on available-for-sale investments 2,283,000 3,989,000
Gain on extinguishment of debt   (18,505,000)
Gain on divested business (120,047,000)  
Stock-based compensation expense 8,601,000 15,291,000
Loss on disposal of property and equipment 149,000 295,000
Change in credit losses 157,000 18,000
Excess and obsolete inventory 110,000  
Change in contingent consideration (5,207,000) (1,329,000)
Changes in operating assets and liabilities:    
Accounts receivable (7,828,000) (1,075,000)
Inventories (2,088,000) 2,716,000
Prepaid expenses and other current assets 4,521,000 454,000
Deposits (185,000) 195,000
Operating lease liabilities (3,967,000) (4,281,000)
Accounts payable and other accrued expenses (2,723,000) (3,022,000)
Accrued compensation and related expenses (209,000) (192,000)
Deferred revenue 288,000 (223,000)
Net deferred tax liability 778,000 (383,000)
Net cash used in operating activities (9,499,000) (10,843,000)
Cash Flows From Investing Activities:    
Purchases of property and equipment (10,972,000) (12,035,000)
Software development costs (2,649,000) (2,761,000)
Purchases of short-term investments   (50,721,000)
Proceeds from divested business 210,239,000  
Acquisitions   (295,000)
Sales/maturities of short-term investments 54,589,000 239,978,000
Patent and trademark costs (940,000) (830,000)
Net cash provided by investing activities 250,267,000 173,336,000
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 3,973,000 648,000
Repurchase of common stock (8,004,000)  
Repayment of notes payable (121,000) (113,000)
Repayment of finance lease liabilities (425,000) (306,000)
Net cash used in financing activities (18,921,000) (163,543,000)
Effect of exchange rates on cash and cash equivalents (11,325,000) (631,000)
Net change in cash and cash equivalents 210,522,000 (1,681,000)
Cash and cash equivalents - beginning of period 45,289,000 46,346,000
Cash and cash equivalents - end of period 255,811,000 44,665,000
Reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:    
Cash and cash equivalents from continuing operations - beginning of period 34,137,000 35,192,000
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - beginning of period 11,152,000 11,154,000
Total cash and cash equivalents - beginning of period 45,289,000 46,346,000
Cash and cash equivalents from continuing operations - end of period 255,811,000 31,366,000
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - end of period   13,299,000
Total cash and cash equivalents - end of period 255,811,000 44,665,000
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 925,000 629,000
Cash paid for income taxes 934,000 1,179,000
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 5,783,000 1,543,000
Net unrealized gain on available-for-sale debt securities 1,336,000 3,219,000
Reclassification of realized gain (loss) on available-for-sale debt securities to earnings 2,916,000 (6,224,000)
Paid-in-kind preferred stock dividend, including beneficial conversion feature 6,000,000 6,000,000
Fixed assets included in accounts payable and accrued liabilities 229,000 27,000
Contingent consideration reclassed to accounts payable and accrued liabilities 881,000  
Purchase of equipment through finance lease obligation 388,000 834,000
2026 Senior Notes    
Cash Flows From Financing Activities:    
Repayment of Convertible Senior Notes 0 $ (163,772,000)
2025 Senior Notes    
Cash Flows From Financing Activities:    
Repayment of Convertible Senior Notes $ (14,344,000)  

Source

10-Q PDF XBRL Zip